Nike Stock Decline: Anatomy of a 79% Collapse

Nike shares have fallen 78.6% from their November 2021 record high. The stock closed at $38.40 on 4 September 2026 against an intraday peak of $179.10 on 5 November 2021. Roughly $224 billion of market value has gone. On 21 September Nike leaves the S&P 100 after an 18-year run, and it is currently the worst-performing stock in the Dow Jones Industrial Average for 2026.

Here is the part that matters to anyone who trades or invests: the business did not fall 78.6%. Nike’s revenue in FY26 was $46.4 billion. In FY21, at the top, it was $44.5 billion. Five years on, the company sells more product than it did at the peak and the equity is worth roughly a fifth of what it was.

That gap between the business and the share price is the entire lesson. This is a case study in how a market re-rates a story, and how quickly a “quality compounder” becomes a “turnaround” in the language investors use to describe the same set of shoes.

The numbers, without the narrative

The 78.6% figure excludes dividends. On a total-return basis the loss is slightly smaller, because Nike kept paying shareholders the whole way down. On an adjusted closing basis the all-time high was $161.91, also set on 5 November 2021. Whichever number you prefer, the shape is the same: a five-year decline that has taken the stock back to levels last seen more than a decade ago.

For 2026 alone, Nike is down roughly 40%. That makes it the worst of the 30 Dow components this year, behind IBM at about −21% and McDonald’s near −16%. It is not a sector story either, although Lululemon is down about 52% over the same stretch. Something specific broke here.

Why the Nike stock decline was two collapses, not one

Most people describe a drawdown like this as sentiment. It is not. A share price is earnings multiplied by what the market will pay for those earnings, and in Nike’s case both halves of that equation fell by roughly half at the same time.

These two forces multiply. Nike now earns about 44% of its FY21 profit, and the market pays about 48% of the old multiple for it. Multiply 0.44 by 0.48 and you get 0.21. The stock sits at roughly 21% of its former value. There is no mystery in the arithmetic.

What actually broke inside the business

The direct-to-consumer bet

Nike’s strategy in the run-up to the peak was to sell more of its own product through its own stores and its own app. On paper it is compelling: better margins, better data, control of the customer relationship. In practice, Nike pulled back from wholesale partners while those partners were still where most people actually discovered, compared and tried on performance footwear. Rivals took the shelf space Nike vacated.

FY26 is the year that reversal became visible in the numbers.

Nike refreshed more than 15,000 spaces inside wholesale doors during FY26, and said revenue growth and retail sales with Foot Locker turned positive in the fourth quarter for the first time in four years. That is genuine progress.

The counterweight: shipping more product into retailers lifts reported revenue before a single extra consumer has bought anything. The number that proves a recovery is sell-through at full price, not sell-in. Until those two move together, wholesale growth is a channel decision, not demand.

The product problem is bigger than one slow category

Nike Running has now delivered five consecutive quarters of double-digit growth and added roughly $1 billion of business over that stretch. Performance categories overall grew mid-single-digit in FY26. That is a working engine.

It is attached to a very large hull. Nike Sportswear and Jordan Streetwear together account for approximately half of company revenue, and both are expected to stay negative through FY27, with improvement only anticipated in the second half. Running can compound at 15% and still not move the group needle while half the business shrinks.

Nike plans more than a dozen new Sportswear footwear styles in the back half of FY27. Announcements are cheap. The test is whether those styles sell at full price, or whether they clear on promotion like the ones before them.

China

Greater China used to be the growth engine that justified the multiple. In FY21 the region produced $8.29 billion of revenue after seven straight years of double-digit currency-neutral growth. In FY26 it produced $5.85 billion. That is close to a 30% decline in five years.

Inventory coming down and average discounts falling are the right signs. Running grew mid-single-digit in the region in Q4, and football and tennis grew double digits. But the aggregate is still deeply negative, which means Nike is losing more in broad lifestyle demand than it is winning back in performance niches.

The competitive picture has also changed underneath it. Anta and Li-Ning are stronger domestically than they were five years ago, and On and Hoka have fragmented the premium performance market globally. Reopening distribution is a logistics problem. Restoring desirability is not.

The refund that flattered FY26

Nike’s FY26 headline numbers look steadier than the underlying business, and the reason is a single line item. The company recognised a $986 million expected recovery of IEEPA tariffs in Q4. That added about 210 basis points to full-year gross margin and $0.52 to earnings per share.

A refund of tariffs already paid is not recurring operating profit, so the right starting point for any valuation work is the right-hand column. Set FY21’s operating margin of approximately 15.6% against an underlying FY26 figure near 6.1% and you can see how much earnings power discounting, product mix and an inefficient cost base have taken out.

This is not a solvency question. At 31 May Nike held $9.0 billion of cash and short-term investments against about $7.9 billion of interest-bearing debt, and generated $2.9 billion of operating cash flow for the year. Nike is not going anywhere. The question is what it earns when it gets where it is going.

The S&P 100 exit is a symptom, not a cause

S&P Dow Jones Indices announced on 4 September that Nike leaves the S&P 100 before the open on 21 September, replaced by Palo Alto Networks. Dell, Arista Networks and SanDisk also enter; Honeywell Aerospace, Simon Property Group and Colgate-Palmolive also leave. Nike remains in the S&P 500, remains in the Dow, and continues to trade normally on the NYSE.

The instinct is to assume forced selling. Check the actual size of it. The iShares S&P 100 ETF (OEF) is the clearest publicly visible pool of index-linked capital tied to that benchmark. BlackRock reported fund assets of about $20.45 billion on 4 September, and the 31 August holdings file showed a 0.10% Nike weight, worth roughly $19.6 million, or 506,524 shares. Approximately 20.6 million Nike shares changed hands on 4 September.

The disclosed ETF position was therefore equivalent to about 2.5% of a single ordinary day’s volume. Other separate accounts and derivative products are not captured in that figure, but the point stands: the symbolism of this deletion is far larger than the flow. If you want to understand how index membership genuinely moves a share price when it is large enough to matter, the mechanics are covered in The Index Machine.

What the deletion actually says is simpler. S&P said the changes were intended to make each index more representative of its market-capitalisation range. Nike is no longer big enough to represent America’s mega-cap tier. The index is not making a judgement about the company. It is recording one the market already made.

Reading the monthly chart

Pull up NKE on a monthly timeframe and the structure tells a cleaner story than the commentary does. The advance from the mid-2010s into November 2021 steepens into something close to vertical, the classic late-stage shape of a crowded trade. Then it breaks. What follows is five years of lower highs and lower lows, and the stock has not reclaimed a prior monthly swing high once in that entire span.

That last clause is the one traders should sit with. Nike has produced several rallies since 2021 that felt like bottoms at the time. Each topped out below the one before it. The stock is now at a twelve-year low, roughly 1% above a 52-week low of $37.95 set on 3 September.

There is a second-order point here about the difference between an investor and a trader. An investor buying Nike at $38 with a five-year horizon and no leverage is running a completely different risk than a trader buying a bounce with a stop. Both can be right. Only one of them can be wrong slowly. Confusing the two is how people end up holding a position they sized like a trade and defend like an investment.

Formula 1, and why brand news is not a thesis

At the end of August, Sports Business Journal reported that Nike has held talks with Formula One Management about a possible sponsorship and licensing arrangement. Nike executives attended the Miami Grand Prix in May. Valtteri Bottas and Sergio Perez have appeared in Cadillac imagery wearing Nike footwear, and custom Cadillac-themed Nike Dunk Lows were made for TWG Motorsports executives. Nike last had a major Formula 1 presence in 2002, when its partnership with Michael Schumacher ended.

Both Nike and Formula 1 declined to comment. No agreement has been reached. Puma already holds significant F1 relationships, so any Nike arrangement would have to be structured around existing team and driver deals.

It is a genuinely interesting commercial story. Formula 1 is one of the fastest-growing properties in global sport, and it is precisely the kind of high-margin lifestyle adjacency Nike needs. It is also, at this stage, a report about conversations.

Note what happens to a beaten-down stock when a story like this circulates. Retail interest spikes on the headline. The bull case gets a new sentence. Nothing in the FY27 numbers changes at all. A sponsorship deal, even a large one, does not fix a 30% revenue decline in China or turn Jordan Streetwear positive. It is a marketing decision being priced by some people as a turnaround signal, and the distinction is worth holding onto.

Is the stock cheap now?

That depends entirely on which earnings number you use, which is exactly why the question is harder than it looks.

• At $38.40 against reported FY26 EPS of $2.10, Nike trades on about 18.3 times earnings.
• Against underlying EPS of $1.58, it trades on about 24.3 times.
• Market value of $56.9 billion is roughly 1.2 times FY26 revenue, down from a price-to-sales ratio near 4.0 in fiscal 2022.
• FY26 dividends declared were $1.63 per share, a historical yield of about 4.2% at the current price.

The dividend needs the same adjustment as the earnings. That payout consumed roughly 78% of reported EPS and slightly more than 100% of underlying EPS. Nike has the liquidity to keep paying it, and spent $2.4 billion on dividends against just $123 million on buybacks in FY26. But a dividend funded out of a profit base that has not recovered is a claim on the balance sheet, not a sign of health.

So the honest answer is that Nike is much cheaper than it was, and is not obviously cheap. At 24 times depressed earnings, the market is already paying for a recovery that has not yet appeared in the accounts.

A framework instead of a target price

Rather than pick a number, it is more useful to ask what has to be true for each outcome. The scenarios below were published by INDmoney as an illustrative framework, not a company forecast, and assume approximately 1.48 billion diluted shares with a low-20% tax rate.

The width of that range is the finding. A stock that can plausibly be worth $28 or $88 in the same 24 months is not a value investment with a margin of safety. It is a bet on management execution, sized accordingly or not sized at all.

What Wall Street is actually saying

The consensus is a study in institutional hedging. The average 12-month price target sits around $50.46, implying roughly 31% upside from $38.40, while the consensus rating is only Neutral. In other words: we think it goes up, and we are not telling you to buy it.

Underneath that average, the recent moves have been downgrades. JPMorgan cut Nike to Underweight in August with a $40 target, arguing that the financial cost of chief executive Elliott Hill’s “Win Now” turnaround will weigh on profits through fiscal 2028, and that a Greater China reset creates more than $1 billion of annual revenue pressure. Truist followed with its own downgrade to a $42 target after weak footwear trends at Dick’s Sporting Goods raised doubts about the pace of recovery.

When an average target implies 31% upside and the most recent revisions cluster at $40–$42, the average is being propped up by stale estimates. That is worth knowing before quoting it as an argument.

Three lessons through Mind, Method and Money

Mind: the anchor is the enemy

Every trader who has watched Nike since 2021 carries a number in their head. For some it is $179, for others $100, or $70, or wherever they first thought it was cheap. That number does nothing except make each successive level feel like a bargain relative to a price the market has already rejected.

Anchoring is why people average down into structural declines. The brand is not the stock. Nike’s swoosh has never been more globally recognised than it is today, and that fact has been perfectly compatible with an 80% loss of market value. If you find yourself justifying a position with the sentence “it’s Nike,” that is the anchor talking. More on the mechanics of that in the psychology of losing.

Method: a story is not a trigger

The S&P 100 exit, the F1 talks, the new commercial chief, the 4.2% dividend yield: all real, none of them entry criteria. A method tells you exactly what price has to do before you commit capital, and it says the same thing on Nike as it does on gold or the Nasdaq. Level, confirmation, invalidation, size. If you cannot write down the price at which you are wrong, you do not have a trade, you have an opinion with money attached.

Money: a falling knife is a position sizing problem

The trader who lost the most on Nike over the past five years was not the one who bought at $179. It was the one who bought at $179, added at $140, added again at $100, and had no stop at any of them. Each addition looked rational in isolation. Together they built a position that could not survive being wrong.

This is the arithmetic of risk of ruin playing out on a blue chip rather than a leveraged forex position, and the fix is the same in both places: fixed risk per idea, a predetermined invalidation, and no adding to a loser. If you want the mechanics, the position sizing guide covers it.

What to watch from here

Three dated events sit in the near term, and each one is a genuine information release rather than a headline.

Beyond the calendar, the operating indicators that separate a real turnaround from a promotional one are straightforward.

Management has changed materially in the last month, which is either the setup for execution or the admission that execution was the problem. David Denton became chief financial officer on 17 August 2026. Jane Ewing, a 14-year Walmart veteran and previously interim chief executive of Sam’s Club China, became chief commercial officer on 7 September, taking global sales and Nike Direct. Given that China and Nike Direct are the two worst-performing parts of the company, the appointment is at least pointed at the right target.

The uncomfortable conclusion

Nike is a genuinely great company having a genuinely bad decade. Both halves of that sentence are true at once, and holding them together is the hard part.

The brand endures. The balance sheet is sound. Running works, wholesale is recovering, and North America grew 5% in FY26. There is a real business here that will very likely still be selling shoes in fifty years.

And the stock has lost roughly four-fifths of its value, still trades on 24 times a depressed earnings base, and has not reclaimed a prior monthly swing high in five years. Both of those are also true.

Markets do not reward you for identifying a great company. They reward you for buying it at a price that leaves room to be wrong. Nike at $179 was a great company at an impossible price. Nike at $38 is a great company at a price that requires management to deliver something they have not yet delivered. The interesting question is not whether Nike survives. It is what you are willing to pay for a recovery you cannot yet see in the accounts, and how much of your capital you are willing to have wrong while you wait.

None of the above is investment advice. It is a case study in how a market reprices a story, written for traders and investors who want to understand the mechanics rather than the headline. Every figure here comes from Nike’s reported FY26 results, S&P Dow Jones Indices announcements, BlackRock fund disclosures and published market data as at 8 September 2026. Do your own work before risking capital.